‘Significant progress’ for life sciences business Optibiotix

Optibiotix says it has made “significant progress” developing a pipeline of innovative products in the first half of the year as it evolves from a technology company to a product firm, following the flotation of its skincare-focused subsidiary and investment in a weight loss business.For the six months ended May 31, 2017, the York-based life sciences business reported a profit after tax of £3.2m following the listing of Skinbiotherapeutics, its skincare-focused subsidiary.The company said the income statement includes an ... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
Close